Skip to main content


Meet with our product experts in one-on-one virtual sessions

Set Up a Meeting
Quick Connect

News

Addressing NDMAs in Pharmaceuticals

Dr. Reddy’s API participated in an exclusive presentation entitled “Addressing NDMAs in Pharmaceuticals” at CPHI on NDMAs in Pharmaceuticals by our Executive Vice President and Head of API Regulatory affairs, E Sreedhar, and our VP and Head of Chemistry (API R&D), Rakeshwar Bandichhor.

Addressing NDMAs in Pharmaceuticals

Contact Us

Please fill in the following form and we'll get back to you shortly.

Disclaimer

No information in this catalog - including any reference to any product or service - constitutes an offer for sale, or be construed as representing an offer for sale. Products protected under valid patents are not offered or supplied for commercial use. However, the research quantities of such products may be offered for the purpose of regulatory submissions, wherever such regulatory exemptions exist. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities. Products protected under valid patents in India are not available for commercial use but would be available for Section 107A purposes.